华峰化学 - Financials

华峰化学 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	26.9B	26.3B	25.9B	28.4B	14.7B
Revenue Growth %	2.4%	1.6%	-8.8%	92.7%	--
Total Revenue	26.9B	26.3B	25.9B	28.4B	14.7B
Cost Of Revenue	23.2B	22.3B	21.2B	17.4B	11.1B
+Gross Profit	3.7B	4.0B	4.6B	11.0B	3.7B
Gross Margin %	13.8%	15.3%	17.9%	38.7%	24.8%
Total Operating Cost	24.8B	23.8B	22.9B	19.3B	12.2B
Selling Expenses	212.0M	194.0M	169.0M	158.0M	126.0M
Admin Expenses	408.0M	430.0M	449.0M	438.0M	327.0M
Rd Expenses	809.0M	901.0M	1.1B	1.0B	510.0M
Finance Expenses	-136.0M	-146.0M	-203.0M	31.0M	63.8M
+Operating Income	2.6B	2.8B	3.2B	9.2B	2.6B
Operating Margin %	9.5%	10.5%	12.4%	32.6%	17.9%
Non Operating Income	23.8M	8.0M	34.5M	6.4M	2.0M
Non Operating Expenses	73.6M	157.0M	56.3M	97.2M	29.8M
Investment Income	127.0M	93.5M	106.0M	69.5M	42.5M
Fair Value Change Income	2.3M	-2.8M	-2.3M	-1.3M	5.0M
Asset Disposal Income	2.6M	-4.0M	-3.7M	-13.7M	-6.9M
Asset Impairment Loss	181.0M	51.7M	89.6M	32.8M	35.1M
Other Income	300.0M	196.0M	147.0M	104.0M	101.0M
Income Before Tax	2.5B	2.6B	3.2B	9.2B	2.6B
Income Tax	287.0M	140.0M	339.0M	1.2B	335.0M
+Net Income	2.2B	2.5B	2.8B	7.9B	2.3B
Net Margin %	8.3%	9.4%	11.0%	28.0%	15.5%
Net Income Attributable	2.2B	2.5B	2.8B	7.9B	2.3B
Minority Interest	6.9M	721,100	-2.0M	-515,800	-368,600
Eps Basic	0.45	0.50	0.58	1.71	0.49
Eps Diluted	0.45	0.50	0.58	1.71	0.49

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	7.1B	10.2B	10.5B	7.5B	4.4B
Trading Financial Assets	1.3B	--	69.3M	227.0M	88.3M
Accounts Receivable	2.5B	2.5B	2.1B	2.0B	1.6B
Notes Receivable	113.0M	299,300	48.9M	40.4M	--
Notes And Accounts Receivable	2.6B	2.5B	2.2B	2.1B	1.6B
Prepayments	778.0M	676.0M	524.0M	604.0M	299.0M
Inventory	3.7B	3.6B	2.8B	4.0B	1.9B
Total Current Assets	18.9B	20.1B	18.7B	18.2B	10.6B
Long Term Equity Investment	852.0M	759.0M	650.0M	568.0M	518.0M
Fixed Assets	--	11.4B	8.1B	7.8B	7.3B
Fixed Assets Total	10.8B	11.4B	8.1B	7.8B	7.3B
Construction In Progress	--	1.5B	3.7B	890.0M	261.0M
Construction In Progress Total	1.7B	1.5B	3.7B	890.0M	261.0M
Intangible Assets	1.4B	1.2B	1.2B	935.0M	597.0M
Long Term Deferred Expenses	136.0M	213.0M	55.2M	55.4M	55.0M
Total Non Current Assets	17.1B	15.5B	14.1B	11.0B	9.1B
Total Assets	36.0B	35.5B	32.8B	29.2B	19.7B
Short Term Borrowings	2.8B	2.6B	2.2B	1.6B	1.8B
Accounts Payable	1.7B	2.0B	1.9B	2.3B	1.5B
Advance Receipts	--	--	--	--	--
Contract Liabilities	227.0M	107.0M	151.0M	146.0M	154.0M
Total Current Liabilities	8.0B	9.0B	7.0B	8.3B	6.0B
Long Term Borrowings	2.2M	370.0M	1.6B	846.0M	1.1B
Total Non Current Liabilities	1.4B	1.6B	2.6B	1.9B	2.1B
Total Liabilities	9.4B	10.6B	9.6B	10.2B	8.1B
Paid In Capital	5.0B	5.0B	5.0B	4.6B	4.6B
Capital Reserve	3.9B	3.9B	3.9B	1.5B	1.5B
Surplus Reserve	746.0M	676.0M	620.0M	464.0M	321.0M
Retained Earnings	16.8B	15.4B	13.7B	12.5B	5.2B
Minority Equity	97.7M	1.5M	392,800	2.6M	3.0M
Equity Attributable	26.5B	24.9B	23.1B	19.0B	11.6B
Total Equity	26.6B	24.9B	23.1B	19.0B	11.6B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	27.8B	24.2B	21.6B	20.4B	13.9B
Tax Refunds Received	194.0M	206.0M	214.0M	3.7M	110.0M
Total Operating Cash Inflow	28.7B	25.2B	22.4B	20.7B	14.4B
Cash Paid For Goods	22.6B	19.7B	16.2B	10.0B	8.2B
Cash Paid To Employees	1.6B	1.6B	1.5B	1.1B	953.0M
Taxes Paid	688.0M	546.0M	1.1B	2.2B	435.0M
Total Operating Cash Outflow	25.7B	22.7B	19.8B	14.5B	10.2B
Operating Cash Flow	3.0B	2.5B	2.6B	6.1B	4.2B
Total Investing Cash Inflow	6.6B	1.0B	2.2B	3.6B	3.4B
Total Investing Cash Outflow	11.0B	2.6B	4.6B	5.9B	6.4B
Investing Cash Flow	-4.4B	-1.6B	-2.4B	-2.2B	-3.0B
Cash From Borrowings	8.3B	6.8B	4.7B	1.8B	5.4B
Dividends And Interest Paid	816.0M	857.0M	1.6B	548.0M	324.0M
Debt Repayments	9.6B	6.5B	3.5B	2.3B	5.8B
Total Financing Cash Inflow	8.6B	6.8B	7.5B	2.0B	7.3B
Total Financing Cash Outflow	10.5B	7.8B	5.1B	2.8B	6.4B
Financing Cash Flow	-1.9B	-945.0M	2.3B	-862.0M	959.0M
Net Change In Cash	-3.2B	-8.4M	2.5B	3.0B	2.1B
Ending Cash Balance	6.5B	9.7B	9.7B	7.1B	4.2B
Capex	1.3B	1.7B	2.6B	2.1B	1.6B